Germany
Japan
United Kingdom
China
Lenti ORF particles, GPR119 (Myc-DDK tagged) - Human G protein-coupled receptor 119 (GPR119), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Products
Lenti ORF particles, MFGE8 (Myc-DDK tagged) - Human milk fat globule-EGF factor 8 protein (MFGE8), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SH2B3 (Myc-DDK tagged) - Human SH2B adaptor protein 3 (SH2B3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, SRSF5 (Myc-DDK tagged) - Human serine/arginine-rich splicing factor 5 (SRSF5), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,524.00
5 Weeks
Lenti ORF particles, IKBKB (Myc-DDK tagged) - Human inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (IKBKB), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SOX5 (Myc-DDK tagged) - Human SRY (sex determining region Y)-box 5 (SOX5), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,152.00
6 Weeks
Lenti ORF particles, TGFBR2 (Myc-DDK tagged) - Human transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,152.00
3 Weeks
Lenti ORF particles, TGFBR2 (mGFP-tagged) - Human transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PCSK9 (Myc-DDK tagged) - Human proprotein convertase subtilisin/kexin type 9 (PCSK9), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TRPV4 (mGFP-tagged) - Human transient receptor potential cation channel, subfamily V, member 4 (TRPV4), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TRPV4 (mGFP-tagged) - Human transient receptor potential cation channel, subfamily V, member 4 (TRPV4), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PTGER3 (Myc-DDK-tagged)-Human prostaglandin E receptor 3 (subtype EP3) (PTGER3), transcript variant 5, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PTGER3 (mGFP-tagged)-Human prostaglandin E receptor 3 (subtype EP3) (PTGER3), transcript variant 5, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CDCP1 (Myc-DDK tagged) - Human CUB domain containing protein 1 (CDCP1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CDCP1 (mGFP-tagged) - Human CUB domain containing protein 1 (CDCP1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
6 Weeks
Lenti ORF particles, SLC18A2 (Myc-DDK tagged) - Human solute carrier family 18 (vesicular monoamine), member 2 (SLC18A2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, SLC18A2 (mGFP-tagged) - Human solute carrier family 18 (vesicular monoamine), member 2 (SLC18A2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, POU3F4 (Myc-DDK tagged) - Human POU class 3 homeobox 4 (POU3F4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, ISM1 (Myc-DDK tagged) - Human isthmin 1 homolog (zebrafish) (ISM1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, ISM1 (mGFP-tagged) - Human isthmin 1 homolog (zebrafish) (ISM1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SLC7A14 (Myc-DDK tagged) - Human solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 (SLC7A14), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CTNND1 (mGFP-tagged) - Human catenin (cadherin-associated protein), delta 1 (CTNND1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, FUT8 (Myc-DDK tagged) - Human fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (FUT8), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, FUT8 (mGFP-tagged) - Human fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (FUT8), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, GAD2 (Myc-DDK tagged) - Human glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) (GAD2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, GAD2 (mGFP-tagged) - Human glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) (GAD2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CMAS (mGFP-tagged) - Human cytidine monophosphate N-acetylneuraminic acid synthetase (CMAS), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, RGS3 (Myc-DDK tagged) - Human regulator of G-protein signaling 3 (RGS3), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, HIST1H1B (mGFP-tagged) - Human histone cluster 1, H1b (HIST1H1B), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, KIR3DL3 (Myc-DDK tagged) - Human killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3 (KIR3DL3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, TP53 (mGFP-tagged) - Human tumor protein p53 (TP53), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
6 Weeks
Lenti ORF particles, NF1 (Myc-DDK tagged) - Human neurofibromin 1 (NF1), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, YAP1 (mGFP-tagged)-Human Yes-associated protein 1 (YAP1), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
TP53 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
NFE2L2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
| E. coli Selection | Kanamycin |
| Mammalian Cell Selection | Puromycin |
STIM1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
EGFR - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
| E. coli Selection | Kanamycin |
| Mammalian Cell Selection | Puromycin |
CD44 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
| E. coli Selection | Kanamycin |
| Mammalian Cell Selection | Puromycin |
pLenti-P2A-Puro, tag free Lenti vector with P2A-Puro, 10 ug
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
HOXA9 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
| E. coli Selection | Kanamycin |
| Mammalian Cell Selection | Puromycin |
PTEN - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
EZH2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
| E. coli Selection | Kanamycin |
| Mammalian Cell Selection | Puromycin |
PRNP - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol (34 ug/ml) |
| Mammalian Cell Selection | Puromycin |
CD274 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol (34 ug/ml) |
| Mammalian Cell Selection | Puromycin |
HIF1A - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
HDAC2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
| E. coli Selection | Kanamycin |
| Mammalian Cell Selection | Puromycin |
STAT3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
CDKN1A - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
CXCR2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol (34 ug/ml) |
| Mammalian Cell Selection | Puromycin |
BIRC5/Survivin - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol (34 ug/ml) |
| Mammalian Cell Selection | Puromycin |
Active filters
Mammalian Cell Selection
- Puromycin
Filter by
Target Symbol
- CREM (126)
- VEGFA (112)
- DISC1 (104)
- MORF4L2 (96)
- PDE9A (92)
- ASPH (90)
- HMGA1 (90)
- H2 (89)
- TPM1 (86)
- BDNF (84)
- MBP (82)
- NRG1 (82)
- CTNND1 (78)
- DTNA (78)
- OPRM1 (78)
- FGFR2 (76)
- KCNQ2 (75)
- TCF7L2 (74)
- SYBU (72)
- ABI1 (71)
- NR1I3 (70)
- PROM1 (67)
- FGFR1 (63)
- GNAS (63)
- ATXN3 (62)
- PDE4D (62)
- ARPP21 (60)
- CAMK2B (60)
- NREP (60)
- PARD3 (60)
- HNRNPF (59)
- TNNT2 (59)
- CD46 (58)
- CEACAM1 (58)
- DMD (58)
- EDA (58)
- EIF5A (58)
- FHL1 (58)
- MEIS2 (58)
- TGIF1 (58)
- CELF2 (57)
- DAG1 (57)
- SMOX (57)
- ABLIM2 (56)
- ADGRG2 (56)
- BIN1 (56)
- GPM6B (56)
- PDLIM5 (56)
- SEPT9 (56)
- SYTL2 (56)
- CD1E (54)
- IGF1 (54)
- ODF2 (54)
- ST3GAL3 (54)
- TFDP2 (54)
- TNNT3 (54)
- PAK3 (53)
- STAU2 (53)
- CD44 (52)
- DMKN (52)
- KCNIP2 (52)
- LDB3 (52)
- MIER1 (52)
- NCALD (52)
- NRP2 (52)
- OXR1 (52)
- PLEKHB1 (52)
- RBFOX2 (52)
- SORBS1 (52)
- STRA6 (52)
- MADD (51)
- NF2 (51)
- PCBP2 (51)
- APTX (50)
- CNOT4 (50)
- ENSA (50)
- FXYD3 (50)
- HNRNPD (50)
- MEN1 (50)
- PDE1C (50)
- RNH1 (50)
- SERPINA1 (50)
- DCLK1 (49)
- NEDD4L (49)
- TRPM3 (49)
- IKBKG (48)
- ISLR2 (48)
- OSBPL9 (48)
- PPHLN1 (48)
- PREPL (48)
- PTPN20 (48)
- RTN4 (48)
- SEMA6D (48)
- TCF3 (48)
- TNIK (48)
- TP63 (48)
- TTC23 (48)
- ZC3H14 (48)
- ABL2 (47)
- CAPN3 (47)
Species
Lentivirus
Vectors
Reporters
Mutants
C-Tag
Families
- Druggable Genome (45344)
- Transmembrane (29957)
- Transcription Factors (11758)
- Secreted Protein (7711)
- Protein Kinase (3536)
- Protease (2810)
- ES Cell Differentiation/IPS (2495)
- Stem cell - Pluripotency (2084)
- GPCR (1928)
- Phosphatase (1244)
- Ion Channels: Other (924)
- Adult stem cells (558)
- Nuclear Hormone Receptor (508)
- Ion Channels: Potassium (500)
- Embryonic stem cells (489)
- Ion Channels: Cys-loop Receptors (292)
- P450 (292)
- Cancer stem cells (272)
- Induced pluripotent stem cells (269)
- Ion Channels: Transient receptor potential (192)
- Stem cell relevant signaling - JAK/STAT signaling pathway (168)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (152)
- Ion Channels: Glutamate Receptors (136)
- Stem cell relevant signaling - DSL/Notch pathway (108)
- Stem cell relevant signaling - Wnt Signaling pathway (104)
- Ion Channels: ATP Receptors (60)
- Ion Channels: Cyclic nucleotide gated (52)
- Ion Channels: Sodium (44)
Pathways
- Metabolic pathways (6968)
- Pathways in cancer (2594)
- MAPK signaling pathway (2058)
- Neuroactive ligand-receptor interaction (1800)
- Cytokine-cytokine receptor interaction (1739)
- Olfactory transduction (1664)
- Regulation of actin cytoskeleton (1558)
- Endocytosis (1370)
- Focal adhesion (1300)
- Chemokine signaling pathway (1244)
- Calcium signaling pathway (1218)
- Purine metabolism (1174)
- Wnt signaling pathway (1156)
- Huntington's disease (1124)
- Neurotrophin signaling pathway (1061)
- Alzheimer's disease (1044)
- Ubiquitin mediated proteolysis (1028)
- Jak-STAT signaling pathway (983)
- Axon guidance (956)
- Natural killer cell mediated cytotoxicity (944)
- Insulin signaling pathway (896)
- Progesterone-mediated oocyte maturation (892)
- Tight junction (890)
- Cell adhesion molecules (CAMs) (887)
- Cell cycle (884)
- Leukocyte transendothelial migration (872)
- Oocyte meiosis (824)
- Lysosome (820)
- T cell receptor signaling pathway (820)
- ErbB signaling pathway (772)
- Adherens junction (762)
- Fc gamma R-mediated phagocytosis (732)
- Prostate cancer (731)
- Toll-like receptor signaling pathway (724)
- Apoptosis (719)
- Hematopoietic cell lineage (713)
- Melanogenesis (709)
- Spliceosome (706)
- Vascular smooth muscle contraction (704)
- Oxidative phosphorylation (700)
- GnRH signaling pathway (692)
- Parkinson's disease (684)
- Dilated cardiomyopathy (680)
- Systemic lupus erythematosus (674)
- Colorectal cancer (651)
- Hypertrophic cardiomyopathy (HCM) (640)
- Pyrimidine metabolism (626)
- Pancreatic cancer (624)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (616)
- VEGF signaling pathway (615)
- Melanoma (588)
- B cell receptor signaling pathway (580)
- TGF-beta signaling pathway (568)
- Gap junction (566)
- PPAR signaling pathway (564)
- p53 signaling pathway (564)
- Chronic myeloid leukemia (560)
- Small cell lung cancer (541)
- Renal cell carcinoma (540)
- Antigen processing and presentation (527)
- Fc epsilon RI signaling pathway (520)
- Viral myocarditis (519)
- Acute myeloid leukemia (513)
- Complement and coagulation cascades (500)
- Glioma (500)
- RIG-I-like receptor signaling pathway (500)
- Adipocytokine signaling pathway (496)
- NOD-like receptor signaling pathway (490)
- Long-term potentiation (488)
- Phosphatidylinositol signaling system (482)
- Ribosome (480)
- Long-term depression (472)
- Glycerophospholipid metabolism (460)
- Epithelial cell signaling in Helicobacter pylori infection (458)
- Cardiac muscle contraction (444)
- Glycolysis / Gluconeogenesis (434)
- Endometrial cancer (432)
- Amyotrophic lateral sclerosis (ALS) (431)
- Drug metabolism - cytochrome P450 (428)
- ECM-receptor interaction (422)
- Metabolism of xenobiotics by cytochrome P450 (412)
- Pathogenic Escherichia coli infection (396)
- Non-small cell lung cancer (392)
- Vibrio cholerae infection (390)
- Basal cell carcinoma (388)
- mTOR signaling pathway (386)
- Bladder cancer (368)
- Cytosolic DNA-sensing pathway (356)
- Inositol phosphate metabolism (354)
- Drug metabolism - other enzymes (348)
- Retinol metabolism (344)
- Arginine and proline metabolism (338)
- Valine (338)
- Arachidonic acid metabolism (336)
- Hedgehog signaling pathway (336)
- Glutathione metabolism (332)
- Starch and sucrose metabolism (310)
- RNA degradation (308)
- Thyroid cancer (308)
- N-Glycan biosynthesis (304)
- Sphingolipid metabolism (292)
- Type II diabetes mellitus (292)
- Glycerolipid metabolism (286)
- Amino sugar and nucleotide sugar metabolism (284)
- Tyrosine metabolism (284)
- Fatty acid metabolism (278)
- leucine and isoleucine degradation (274)
- Autoimmune thyroid disease (267)
- Pyruvate metabolism (262)
- Lysine degradation (255)
- Cysteine and methionine metabolism (252)
- Primary immunodeficiency (252)
- Taste transduction (252)
- Proteasome (250)
- ABC transporters (246)
- Base excision repair (246)
- Nucleotide excision repair (244)
- Type I diabetes mellitus (239)
- Tryptophan metabolism (238)
- Notch signaling pathway (236)
- SNARE interactions in vesicular transport (236)
- Ether lipid metabolism (232)
- Alanine (224)
- aspartate and glutamate metabolism (224)
- Androgen and estrogen metabolism (220)
- Porphyrin and chlorophyll metabolism (220)
- Fructose and mannose metabolism (216)
- Graft-versus-host disease (215)
- Prion diseases (214)
- Aminoacyl-tRNA biosynthesis (212)
- Butanoate metabolism (206)
- Glycine (204)
- serine and threonine metabolism (204)
- Citrate cycle (TCA cycle) (200)
- Glycosphingolipid biosynthesis - lacto and neolacto series (192)
- Allograft rejection (191)
- Propanoate metabolism (190)
- Basal transcription factors (188)
- DNA replication (188)
- Galactose metabolism (184)
- Selenoamino acid metabolism (180)
- Pentose phosphate pathway (176)
- Nitrogen metabolism (172)
- Histidine metabolism (166)
- Glycosaminoglycan degradation (164)
- Homologous recombination (164)
- O-Glycan biosynthesis (164)
- Regulation of autophagy (164)
- Linoleic acid metabolism (160)
- Maturity onset diabetes of the young (156)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (152)
- Nicotinate and nicotinamide metabolism (150)
- Dorso-ventral axis formation (144)
- Mismatch repair (144)
- Phenylalanine metabolism (136)
- RNA polymerase (136)
- Asthma (132)
- Pentose and glucuronate interconversions (132)
- Heparan sulfate biosynthesis (128)
- Primary bile acid biosynthesis (128)
- beta-Alanine metabolism (126)
- Biosynthesis of unsaturated fatty acids (124)
- Keratan sulfate biosynthesis (124)
- Ascorbate and aldarate metabolism (118)
- Pantothenate and CoA biosynthesis (118)
- One carbon pool by folate (116)
- Renin-angiotensin system (116)
- Riboflavin metabolism (114)
- Chondroitin sulfate biosynthesis (112)
- Other glycan degradation (110)
- Sulfur metabolism (108)
- alpha-Linolenic acid metabolism (108)
- Steroid biosynthesis (100)
- Glycosphingolipid biosynthesis - globo series (96)
- Terpenoid backbone biosynthesis (96)
- Non-homologous end-joining (92)
- leucine and isoleucine biosynthesis (92)
- Glyoxylate and dicarboxylate metabolism (88)
- Glycosphingolipid biosynthesis - ganglio series (84)
- Cyanoamino acid metabolism (76)
- Taurine and hypotaurine metabolism (76)
- Limonene and pinene degradation (74)
- C21-Steroid hormone metabolism (72)
- Circadian rhythm - mammal (72)
- Folate biosynthesis (68)
- Caffeine metabolism (64)
- Synthesis and degradation of ketone bodies (56)
- Protein export (52)
- Thiamine metabolism (52)
- Fatty acid elongation in mitochondria (48)
- Methane metabolism (44)
- Ubiquinone and other terpenoid-quinone biosynthesis (40)
- Lipoic acid metabolism (28)
- O-Mannosyl glycan biosynthesis (28)
- Fatty acid biosynthesis (24)
- Phenylalanine (24)
- Vitamin B6 metabolism (24)
- tyrosine and tryptophan biosynthesis (24)
- Lysine biosynthesis (20)
- D-Glutamine and D-glutamate metabolism (16)
- Biotin metabolism (8)
- D-Arginine and D-ornithine metabolism (4)